Strs Ohio Ionis Pharmaceuticals Inc Transaction History

Strs Ohio

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$42.03 - $53.55 $217,967 - $277,710	5,186 Added 20.93%	29,965 $1.3 Million
Q4 2023 Jan 30, 2024	BUY	$43.39 - $51.63 $1.08 Million - $1.28 Million	24,779 New	24,779 $1.25 Million
Q4 2022 Jan 26, 2023	BUY	$37.12 - $46.52 $314,888 - $394,629	8,483 Added 49.01%	25,791 $974,000
Q3 2022 Oct 27, 2022	BUY	$36.54 - $48.66 $632,434 - $842,207	17,308 New	17,308 $765,000
Q2 2021 Jul 26, 2021	SELL	$34.54 - $47.25 $50,221 - $68,701	-1,454 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$45.3 - $60.27 $65,866 - $87,632	1,454 New	1,454 $82,000
Q3 2019 Oct 21, 2019	SELL	$59.06 - $72.15 $181,196 - $221,356	-3,068 Closed	0 $0
Q2 2019 Jul 25, 2019	BUY	$62.09 - $86.14 $35,142 - $48,755	566 Added 22.62%	3,068 $197,000
Q1 2019 Apr 19, 2019	BUY	$52.92 - $81.17 $132,405 - $203,087	2,502 New	2,502 $203,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.